ADIPOQ and fatty liver disease: A transgenic ob/ob mouse model overexpressing adiponectin has been shown to have improved glucose tolerance, reduced serum lipids and hepatic steatosis, possibly due, in part, to the ability of adipose tissue to expand and prevent lipid spillover [138].